Lipid and lipoprotein patterns in type 2 non-obese diabetic patients. Do Lp(a) levels decrease with improved glycemic...

Area of Science:

• Endocrinology and Metabolism
• Cardiovascular Disease Research
• Lipidology

Background:

• Investigated lipid and lipoprotein profiles in non-obese type 2 diabetes mellitus patients.
• Compared patients undergoing different treatments against a non-diabetic control group.

Purpose of the Study:

• To assess the impact of diabetes mellitus treatments on lipid and lipoprotein levels.
• To evaluate lipoprotein(a) [Lp(a)] levels in relation to treatment modalities.

Main Methods:

• Compared lipid parameters including apolipoprotein-AI (apo-AI), apolipoprotein-B (apo-B), triglyceride (TG), HDL-C, LDL-C, total cholesterol, and Lp(a).
• Patients were stratified into insulin, sulfonylurea, and untreated groups, all non-obese.
• Groups were matched for sex, weight, diabetes duration, and habits.

Main Results:

• No significant differences were observed in apo-AI, apo-B, and TG levels across treatment groups.
• High-density-lipoprotein-cholesterol (HDL-C) levels were significantly lower in the untreated group.
• Lipoprotein(a) [Lp(a)] levels were significantly higher in the untreated type 2 diabetes mellitus group.

Conclusions:

• Metabolic control in diabetes mellitus is essential for managing lipid profiles and mitigating coronary artery disease (CAD) risk factors.
• Insulin or sulfonylurea therapy demonstrates a significant reduction in Lp(a) levels in non-obese type 2 diabetes mellitus patients.
• Effective glycemic control is crucial for improving cardiovascular risk profiles in diabetic individuals.